tradmap

DFTX Earnings Definium Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$3 -$2 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$184M -$92M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-123% -61% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$77M -$39M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income
Return on equity (quarterly)
-52% -26% 0% Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-2.152026-08-0610-Q
Q1 20262026-03-31-0.712026-05-0710-Q
FY 20252025-12-31-2.062026-02-2610-K
Q3 20252025-09-30-1.562025-11-0610-Q
Q2 20262025-06-30-0.812026-08-0610-Q
Q1 20262025-03-31-0.352026-05-0710-Q
FY 20252024-12-31-1.542026-02-2610-K
Q3 20252024-09-30-1.122025-11-0610-Q
Q2 20252024-06-30-1.012025-07-3110-Q
Q1 20252024-03-31-1.142025-05-0810-Q
FY 20242023-12-31-2.442025-03-0610-K
Q3 20242023-09-30-1.852024-11-0710-Q
Q2 20242023-06-30-1.412024-08-1310-Q
Q1 20242023-03-31-0.652024-05-0810-Q
FY 20232022-12-31-1.842024-02-2810-K
Q3 20232022-09-30-1.822023-11-0210-Q
Q2 20232022-06-30-1.262023-08-0310-Q
Q1 20232022-03-31-0.662023-05-0410-Q
FY 20222021-12-31-3.402023-03-0910-K
Q3 20222021-09-30-2.812022-11-1010-Q
Q2 20222021-06-30-0.152022-08-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.